ArticleMedComm2024

Reduced intestinal-to-diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinoma.

Lei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.